Previous Frame Next Frame
  • treatments for sick children

    Techulon's New MRSA Drug Demonstrates Superior Results

    Learn More

  • fighting infectious diseases

    Our research is providing new treatments for intractable diseases

    Learn More

  • reducing risk of deadly infections

    Techulon is Helping Reduce the Risk of Deadly Infections to our US Forces

    Learn More

  • reducing risk of deadly infections

    World Health Organization Declares Antibiotic Resistance a Serious Worldwide Health Threat

    Learn More

  • Slide 1
  • Slide 2
  • Slide 3
  • Slide 4
Targeted Solutions for Targeted Diseases

Our Platform

Our scalable platform improves discovery outcomes and lowers healthcare expenses.

Our Approach

Our targeted therapeutics opens new treatment options for physicians to improve patient care.

Our Programs

Our current pipeline of therapeutic candidates target infectious diseases with a focus on MRSA.